1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - IVDs, LDTs, FDA and CLIA. Understanding the alphabet soup of laboratory assays"}],["$","meta","1",{"name":"description","content":"Laboratory assays (in vitro diagnostics, IVDs) performed on biological specimens are integral to research and clinical care. Both the FDA and CMS (CLIA) regulate laboratory assays, with distinct requirements and responsibilities. Research teams must be aware when FDA or CLIA regulations apply to the use and reporting of results from in vitro testing of biospecimens.

Objectives for this session:

Understand the difference between the CLIA and FDA regulations
Understand when an assay is an investigational device and subject to FDA regulations
Understand when CLIA applies
Learn about the process of obtaining CLIA certification

"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - IVDs, LDTs, FDA and CLIA. Understanding the alphabet soup of laboratory assays"}],["$","meta","4",{"property":"og:description","content":"Laboratory assays (in vitro diagnostics, IVDs) performed on biological specimens are integral to research and clinical care. Both the FDA and CMS (CLIA) regulate laboratory assays, with distinct requirements and responsibilities. Research teams must be aware when FDA or CLIA regulations apply to the use and reporting of results from in vitro testing of biospecimens.

Objectives for this session:

Understand the difference between the CLIA and FDA regulations
Understand when an assay is an investigational device and subject to FDA regulations
Understand when CLIA applies
Learn about the process of obtaining CLIA certification

"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/d044a132-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/bd0311b5-e6fd-4d67-a26c-0ca0a6b4e691.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - IVDs, LDTs, FDA and CLIA. Understanding the alphabet soup of laboratory assays"}],["$","meta","11",{"name":"twitter:description","content":"Laboratory assays (in vitro diagnostics, IVDs) performed on biological specimens are integral to research and clinical care. Both the FDA and CMS (CLIA) regulate laboratory assays, with distinct requirements and responsibilities. Research teams must be aware when FDA or CLIA regulations apply to the use and reporting of results from in vitro testing of biospecimens.

Objectives for this session:

Understand the difference between the CLIA and FDA regulations
Understand when an assay is an investigational device and subject to FDA regulations
Understand when CLIA applies
Learn about the process of obtaining CLIA certification

"}],["$","meta","12",{"name":"twitter:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/bd0311b5-e6fd-4d67-a26c-0ca0a6b4e691.jpg"}],["$","link","13",{"rel":"icon","href":"/favicon.ico","type":"image/x-icon","sizes":"512x512"}],"$L22"],"error":null,"digest":"$undefined"}